Orchard Therapeutics Appoints Braden Parker as Chief Commercial Officer

Go back to Orchard Therapeutics Appoints Braden Parker as Chief Commercial Officer
(NASDAQ: ORTX) Delayed: 16.70 --0 (-0%)
Previous Close $16.70    52 Week High $ 
Open $67.14    52 Week Low $ 
Day High $16.70    P/E N/A 
Day Low $16.70    EPS $ 
Volume 380,258